Localized irregularities in hemoglobin flow and oxygenation in calf muscle in patients with peripheral vascular disease detected with near-infrared spectrophotometry  by Wolf, Ursula et al.
Localized irregularities in hemoglobin flow and
oxygenation in calf muscle in patients with
peripheral vascular disease detected with near-
infrared spectrophotometry
Ursula Wolf, MD,a Martin Wolf, PhD,a Jee H. Choi, MS,a Moshe Levi, MD,b
Devasmita Choudhury, MD,b Sherri Hull, BS,b Daniel Coussirat,b L. Adelina Paunescu, PhD,a
Larisa P. Safonova, PhD,a Antonios Michalos, MD,a William W. Mantulin, PhD,a and
Enrico Gratton, PhD,a Champaign, Ill; and Dallas, Tex
Purpose: Near-infrared spectrophotometry is used to measure flow, concentration, and oxygenation of hemoglobin in
arterioles, capillaries, and venules several centimeters deep in tissue. The purpose of this study was to investigate the
distribution of flow, concentration, and oxygenation of hemoglobin in calf muscle in patients with documented
peripheral arterial occlusive disease (PVD), patients with risk factors for PVD ,and healthy younger subjects at rest.
Method: With a frequency-domain near-infrared spectrophotometer and a specially designed probe, we generated maps at
22 locations simultaneously of hemoglobin flow, concentration, and oxygenation, with the venous occlusion method.
Eight legs of 7 patients with diagnosed PVD (PVD group), 10 legs of 8 patients with normal ankle-brachial index but
with risk factors for PVD (RF group), and 16 legs of 8 healthy subjects (H group) were studied.
Results: Global mean values were significantly (P < .05) different between the three groups for oxygen consumption
(PVD group, 0.027  0.009 mL/100 g/min; RF group, 0.038  0.017 mL/100 g/min; H group, 0.022  0.020
mL/100 g/min), venous oxygen saturation (PVD, 59.7%  15.4%; RF, 69.6%  10.5%; H, 80.8%  4.5%), and, at 60 s
of venous occlusion, concentration changes in oxyhemoglobin (PVD, 4.48  3.25 mol/L; RF, 8.44  2.33 mol/L;
H, 6.85  4.57 mol/L), deoxyhemoglobin (PVD, 3.60  0.73 mol/L; RF, 4.39  1.30 mol/L; H, 2.36  1.79
mol/L), and total hemoglobin (PVD, 8.07 3.83 mol/L; RF, 12.83 2.75 mol/L; H, 9.21 6.34 mol/L). No
significant difference was found between the three groups for hemoglobin flow (PVD, 0.92 0.69 mol/100 mL/min;
RF, 1.68 0.50 mol/100 mL/min; H, 1.44 1.17 mol/100 mL/min) and blood flow (PVD, 0.45 0.28 mL/100
g/min; RF, 0.77  0.21 mL/100 g/min; H, 0.62  0.50 mL/100 g/min). All parameters featured a distribution
dependent on location.
Conclusion: Mean value for venous oxygen saturation was higher in healthy subjects compared to patients with
documented PVD. In patients with PVD, areas of lower oxygenation were clearly discernible. At distal locations of calf
muscle, significant correlations between reduced hemoglobin flow, venous oxygen saturation, oxyhemoglobin, and total
hemoglobin and reduced ankle-brachial index were found. Maps revealed localized irregularities in oxyhemoglobin, total
hemoglobin, and venous oxygen saturation in patients with PVD.
Near-infrared spectrophotometry is a noninvasive bedside technique that can enable determination of blood flow and
oxygenation in tissue and may provide a method for evaluating patients with PVD. (J Vasc Surg 2003;37:1017-26.)
In recent years, near-infrared spectrophotometry
(NIRS) has been used increasingly to measure flow, con-
centration, and oxygenation of hemoglobin in the brain,1,2
skeletal muscle, muscle flaps,3,4 and individual organs.5
Measurements of skeletal muscle have been performed in
athletes6 and in patients with myopathies,7-9 heart fail-
ure,10-12 and peripheral arterial occlusive disease
(PVD).13-19 NIRS has also been used to monitor blood
perfusion and oxygenation during surgery20 and in inten-
sive care medicine.21,22
NIRS is based on the principle of light attenuation by
tissue, and it has the unique ability to noninvasively mea-
sure tissue oxygenation and hemoglobin concentration at a
depth of several centimeters, specifically, at the level of
arterioles, capillaries, and venules.23 Real-time measure-
ments (6 Hz), good spatial resolution (5 mm), bedside
feasibility, and high reproducibility could make this
method a valuable tool to provide insight into the distribu-
tion of hemoglobin flow, concentration, and oxygenation
in the clinical setting.
Most NIRS instruments measure only at one discrete
location. However, previous studies indicated that hemo-
globin flow, concentration, and oxygenation in muscle
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demonstrate variability throughout the muscle at rest24-26
and during exercise.27
The purpose of this study was to advance NIRS to
generate maps and to demonstrate the spatial distribution
of hemoglobin flow, concentration, and oxygenation in
human calf muscle in patients with PVD, patients with risk
factors for PVD, and healthy subjects.
MATERIAL AND METHODS
Principle
NIRS is based on the principle that near-infrared light
propagates through biologic tissue and can be re-collected
by detectors at a given distance from the light source (Fig
1). When NIR light is sent through tissue, only part of the
emitted light reaches the detector, because tissue attenuates
the propagating light; ie, it is absorbed or scattered. From
the intensity of the re-collected light, information about
the traversed tissue can be obtained and oxyhemoglobin
(O2Hb) and deoxyhemoglobin (HHb) concentrations can
be determined with spectral analysis.
Instrument
Measurements were obtained with a frequency-domain
spectrophotometer (Oxy-Imager, ISS, Champaign, Ill),
which uses intensity-modulated light at a frequency of 110
MHz.28 In brief, the instrument uses laser diodes at two
wavelengths, 830 and 758 nm, corresponding to the high
absorption of O2Hb and HHb, respectively. The light of
32 laser diodes (16 per wavelength) is conducted from the
instrument to the tissue and back with optical glass fibers.
Sensor
An area 18.5  6 cm (Fig 2) is covered by the sensor
and enables simultaneous measurements at 22 locations.
Protocol
To measure flow, concentration, and oxygenation of
hemoglobin, we used the venous occlusion method, which,
in comparison with ischemia tests, enables us to measure
venous oxygen saturation (SvO2), hemoglobin flow, and
oxygen consumption (VO2) simultaneously. Moreover, it is
not painful and can be easily repeated. Calculation of VO2
with venous occlusion has been validated against an inva-
sive technique,29 with both the venous and arterial occlu-
sion methods providing similar results.30 Measurements of
SvO2
31 and blood flow32 have been validated against other
methods.
For 15 minutes before measurements were obtained,
all patients and healthy subjects rested in a quiet room with
constant temperature. They reclined comfortably in a su-
pine position with both legs elevated slightly above heart
level to provide quick venous drainage between venous
occlusions. The sensor was placed and secured with an
elastic band along the lateral side of the calf (lateral gastroc-
nemius muscle), and a pneumatic cuff was wrapped around
the thigh. Venous occlusion was induced (within 2 sec-
onds) by inflating the pneumatic cuff to a pressure of 60
mm Hg. Venous occlusion was maintained for 60 seconds
for the first venous occlusion and for 180 seconds for the
final venous occlusion. Between 3 and 5 venous occlusions
were performed. At the end of each venous occlusion the
pneumatic cuff pressure was quickly released. The pressure
curve was recorded with a digital manometer (Cole Parmer,
Vernon Hills, Ill). Consecutive venous occlusions were
separated by 2-minute rest periods. This protocol was
approved by the Institutional Review Board of the Univer-
sity of Illinois at Urbana-Champaign (IRB #94125) and
the Veterans Affairs North Texas Health Care System,
Dallas, Tex.
Measurement of adipose tissue thickness
Adipose tissue thickness of the calf was measured with a
skinfold caliper (Lange, Beta Technology, Inc, Santa Cruz,
Calif).
Measurement of ankle-brachial index
According to standard procedures of the Veterans Af-
fairs North Texas Health Care System, ankle-brachial index
(ABI) was determined by the ratio of systolic blood pres-
sure at the ankle (dorsalis pedis artery or posterior tibial
artery) over systolic blood pressure at the arm (brachial
artery).
Data analysis
Relative changes in [O2Hb] and [HHb] in all 22
locations were calculated from light attenuation changes
with frequency-domain NIRS algorithms.33-35
Two different time courses of venous occlusion are
presented in Fig 3, and the following parameters were
derived from time tracings of changes in [O2Hb] and
[HHb]:
1. Hemoglobin concentration changes in oxyhemoglobin
([O2Hb]), deoxyhemoglobin ([HHb]), and total
hemoglobin ([tHb]), where [tHb] equals the sum of
[O2Hb] and [HHb]. Increases in [O2Hb],
[HHb], and [tHb] were calculated by subtracting
the mean baseline value obtained from the last 10 sec-
onds before the venous occlusion from the mean value
Fig 1. Light is emitted at source location. It penetrates tissue
before being detected at a given distance from source. Shaded area
(light bundle) indicates approximate path of light.
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between 50 and 60 seconds and between 170 and 180
seconds, respectively, of the venous occlusion.
2. Hemoglobin flow was calculated from the first 15 sec-
onds of the increase in [tHb] with the slope of a linear
regression.32 Blood flow was calculated with the hemo-
globin blood concentration.
3. SvO2 was calculated with a linear regression of [O2Hb]
and [tHb] during the first 15 seconds of venous occlu-
sion.31
4. VO2 was calculated with linear regression for the in-
crease in [HHb] over the first 15 seconds of venous
occlusion,36 because increase in [HHb] mainly reflects
conversion of O2Hb into HHb generated by VO2.
Statistics
Correlation to ankle-brachial index. Since at high
ankle pressure the ABI may be falsely too high,37 ABI
Fig 3. Two tracings of changes in [O2Hb] and [HHb] and pneumatic cuff pressure during venous occlusion. The two
diagrams display tracings obtained from two different subjects at the same location on calf muscle. In all venous
occlusions [O2Hb] and [HHb] increase (left), while in one venous occlusion of 180-second duration (right) [O2Hb],
after initial increase, decreases.
Fig 2. System setup. Sensor is placed on lateral calf, where it interrogates an area 18.5  6 cm.
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values in patients with ankle pressure more than 175 mm
Hg were excluded. Both groups of patients were combined
to get a broader range of ABI values. The significance of the
correlation was determined with Spearman’s rho.
Differences. To test for statistical significance of dif-
ferences, we used the Kruskal-Wallis test for data with more
than two groups, the Wilcoxon test for paired data, and the
Mann-Whitney U test for unpaired data.
Subjects
Patients with PVD. Legs with diagnosed PVD were
identified with either ABI less than 0.9, status after surgery,
or pathologic findings at angiography. Eight legs of 7 male
patients with PVD with mean age of 69 years (range, 50-77
years) were included in the study.
Patients at risk. The study included 10 legs of 8 male
patients with mean age of 66 years (range, 51-79 years)
with normal ABI (0.9) but one or more risk factors for
PVD: cardiovascular risk factors including hypertension,
hyperlipidemia, tobacco smoking, diabetes mellitus, or cor-
onary heart disease.
Healthy subjects. Sixteen legs of 8 healthy subjects (5
male, 3 female) with a mean age of 35 years (range, 23-44
years) were measured.
All subjects and patients gave written informed consent
prior to measurement.
RESULTS
Mean values per leg. Global mean values for flow,
concentration, and oxygenation of hemoglobin parameters
for all three groups of subjects are shown in Table I. There
were significant differences between the three groups, par-
ticularly for VO2 and SvO2, whereas hemoglobin flow and
blood flow were not significantly different.
We found a decrease in [O2Hb] during the later part
of the 180 seconds of venous occlusion in 39.8% of mea-
sured locations in patients with PVD and in 66.8% of
patients with risk factors for PVD, which is much greater
than in healthy subjects (21.9%).
From the repeated measurements we calculated an
error of measurement of 7% to 10% for [O2Hb],
[HHb], and [tHb] and 17% to 20% for hemoglobin
flow, blood flow, VO2, and SvO2 in patients with PVD and
patients with risk factors for PVD. In healthy subjects the
error of measurement was similar.
In healthy subjects the difference between the left and
right legs was not significant for any parameter.
Correlation with ankle-brachial index. ABI corre-
lated with [O2Hb] at 60 seconds of venous occlusion
(P .010),[tHb] at 60 seconds of venous occlusion (P
.008), SvO2 (P  .019), and hemoglobin flow (P  .003)
measured in the distal region. The correlation between ABI
and [tHb], hemoglobin flow, and SvO2 is shown in Fig 4.
The correlation for [O2Hb] after 60 seconds of venous
occlusion is similar to that for [tHb] after 60 seconds of
venous occlusion and is therefore not depicted. Inasmuch
as in arteriosclerosis the ABI can be falsely high, data for
patients with ABI higher than 1.1 and ankle pressure higher
than 175 mm Hg are not shown in these graphs.
Maps. There were significant differences between the
proximal and distal regions of calf muscle in healthy sub-
jects (Table II). These differences were much less pro-
nounced in patients.
Maps, corresponding to the area of the sensor, for 1
healthy subject and 5 patients are shown in Figs 5 and 6.
Localized irregularities in hemoglobin concentration and
oxygenation parameters are clearly visible in the maps for
the patients.
Table I. Hemodynamic and oxygenation parameters
Patients with
documented PVD
Patients at risk
for PVD Healthy subjects P A B C
Number of legs 8 10 16
[O2Hb] 60 s (mol/L) 4.48  3.25 8.44  2.33 6.85  4.57 .038 * NS NS
[HHb] 60 s (mol/L) 3.60  0.73 4.39  1.30 2.36  1.79 .001 NS † †
[tHb] 60 s (mol/L) 8.07  3.83 12.83  2.75 9.21  6.34 .022 * NS *
[O2Hb] 180 s (mol/L) 8.06  6.11 9.21  4.28 9.80  4.55 NS
[HHb] 180 s (mol/L) 10.37  2.76 9.48  2.95 6.38  3.07 .002 NS † *
[tHb] 180 s (mol/L) 18.42  7.95 18.69  5.02 16.18  7.32 NS
HF (mol/100 mL/min) 0.92  0.69 1.68  0.50 1.44  1.17 NS
BF (mL/100 g/min) 0.45  0.28 0.77  0.21 0.62  0.50 NS
VO2 (mL/100 g/min) 0.027  0.009 0.038  0.017 0.022  0.020 .009 NS NS *
SvO2 (%) 59.7  15.4 69.6  10.5 80.8  4.5 .00009 NS
‡ ‡
Value represent mean  SD.
, Increase during venous occlusion after 60 or 180 seconds; O2Hb, oxyhemoglobin; HHb, deoxyhemoglobin; tHb, total hemoglobin; HF, hemoglobin flow;
BF, blood flow; VO2, oxygen consumption; SvO2, venous oxygen saturation. P, Significance between all three groups; A, significance of difference between
patients with documented PVD and patients with risk factors for PVD; B, significance of difference between patients with documented PVD and healthy
subjects; C, significance of difference between patients with risk factors for PVD and healthy subjects; NS, not significant.
Statistical comparisons between two groups were only calculated when Kruskal-Wallis test showed significant variability (P) between the three groups.
*P  .05.
†P  .005.
‡P  .0005.
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Variability for [HHb] after 60 and 180 seconds of
venous occlusion, [tHb] after 180 seconds of venous
occlusion, VO2, and SvO2 within maps was significantly
higher for patients compared with healthy subjects.
DISCUSSION
Hemoglobin flow, blood flow, and tHb accumula-
tion. Although at rest mean blood flow in patients with
documented PVD (0.45  0.28 mL/100 g/min) was
considerably lower than in patients with risk factors for
PVD (0.77  0.21 mL/100 g/min) or healthy subjects
(0.62  0.50 mL/100 g/min), this difference was not
statistically significant. This finding and the values mea-
sured for blood flow are in agreement with results from
Kooijman et al,17 who reported median blood flow of 0.56
mL/100 g/min in patients and 0.65 mL/100 g/min in
healthy subjects. Another study38 found mean blood flow
of 1.34 mL/100 g/min in patients and 0.70 mL/100
g/min in healthy subjects. In a study that used positron-
emission tomography (PET),39 mean blood flow was 2.3 to
8.4 mL/100 g/min in patients and 2.2 to 9.3 mL/100
g/min in control subjects. The results given in the litera-
ture were generated by single location measurement, and
no correlation with stage of PVD was established.
With respect to oxygenation, hemoglobin flow is more
relevant than blood flow, which comprises hemoglobin and
plasma, because hemoglobin is the main oxygen carrier in
the blood and the oxygen content in the plasma is negligi-
ble. A strength of our method is that it determines hemo-
globin flow.
We found a correlation with ABI when distal hemoglo-
bin flow values were considered. With decreasing ABI,
hemoglobin flow decreased (Fig 4, B). This result indicates
that with progressing PVD, which is reflected by decreasing
ABI, perfusion decreases. As a consequence of diminished
perfusion, the decreasing SvO2 with declining ABI can be
understood (Fig 4, C).
Mean [tHb] in 60 seconds, which is related to hemo-
globin flow and blood flow because it signifies rate of
accumulation of hemoglobin in tissue, shows a significant
difference between patients with risk factors for PVD and
healthy subjects or patients with PVD. When the distal
region was considered, with increasing ABI a larger increase
in [tHb] after 60 seconds was observed (Fig 4, A), which
can be explained by the impaired hemoglobin flow in
patients with low ABI.
VO2 and HHb accumulation. Mean VO2 was higher
in patients with risk factors for PVD than in the healthy
subjects, 0.038  0.017 mL/100 g/min and 0.022 
0.020 mL/100 g/min, respectively. In patients with doc-
umented PVD, VO2 was 0.027  0.009 mL/100 g/min),
similar to that in healthy subjects. Krageli et al40 found that
VO2 was not significantly lower in patients with PVD
(0.065  0.019 mL/100 g/min) compared with control
subjects (0.071  0.019 mL/100 g/min). Kooijman et
al17 reported a higher median value for VO2 in patients with
PVD (0.055 mL/100 g/min) compared with control sub-
jects (0.047 mL/100 g/min), although the difference was
not significant at rest. After walking exercise, patients had
higher VO2 compared with control subjects (7.60 mL/100
g/min vs 3.30 mL/100 g/min). The 75th percentile was
considerably higher in patients compared with control sub-
jects. This indicates that differences between the two
groups may be larger, had a mean been calculated. Other
studies reported mean VO2 values of 0.16 mL/100 g/min
for patients and 0.10 mL/100 g/min for healthy sub-
jects,38 median VO2 of 0.1 mL/100 g/min for patients
(interquartile range, 0.04-0.16 mL/100 g/min) and 0.2
mL/100 g/min (interquartile range, 0.16-0.24 mL/100
g/min) for healthy subjects, and a broad overlap between
the two groups,19,38 and a VO2 range of 0.08 to 0.15
Fig 4. Correlation between ankle-brachial index (ABI) and
[tHb], hemoglobin flow (HF), and SvO2 for distal region of calf
muscle.
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mL/100 g/min in patients and 0.08 to 0.66 mL/100
g/min in control subjects with PET measurement.39 There
is broad variation between studies. Our values are in the
lower range because we averaged over a whole region,
including regions with low VO2, ie, both the distal and
lateral part of the calf muscle. Yet the origin of the higher
VO2 in the patients remains unclear.
The mean [HHb] at 60 seconds (Table I) was higher
in the patients, which is related to increased VO2 in this
group.
O2Hb accumulation. To calculate blood flow, ve-
nous occlusion is usually maintained for no more than 60
seconds. When we extended occlusion time to 180 seconds
after an initial increase, a decrease in [O2Hb] appeared in
some subjects and some locations, while [tHb] was still
increasing. The declining [O2Hb] indicates that arterial
inflow cannot counterbalance conversion of O2Hb into
HHb because of VO2. The effect was observed three times
more frequently in patients with risk factors for PVD than
in healthy subjects. If it were facilitated by an insufficiency
of oxygen supply, the higher VO2 in patients with risk
factors for PVD would enhance that effect.
SvO2. Mean SvO2 was highly significantly lower in
patients with documented PVD or with risk factors for
PVD compared with healthy subjects. It is noteworthy that
the standard deviation was much wider in the two patient
groups (Table I), which reflects the variety of disease stage
in the patients. Lower tissue oxygen saturation in patients
compared with a control group measured with NIRS was
previously reported.41
Proximal-distal differences. In healthy subjects we
found significantly higher values in the proximal region
compared with the distal region of calf muscle for hemo-
globin flow, blood flow (in agreement with the litera-
ture42), hemoglobin concentration increase, and VO2 (Ta-
ble II). In patients the regional differences showed much
more variability and were thus rarely significant (Table II).
Regional differences can be explained by decreased muscle
mass in the distal part.
SvO2, in contrast, was significantly higher distally. Of
interest, in patients with documented PVD, SvO2 was lower
distally, which indicates that oxygenation is lower distally.
This correlates with the course of the disease.
Maps of hemoglobin accumulation and SvO2. To
illustrate the spatial distribution of the most important
parameters in flow, concentration, and oxygenation of he-
moglobin, we created maps by backprojection. To the best
of our knowledge, the present study is the first to map
hemoglobin flow, concentration, and oxygenation over a
large area in calf muscle in patients with PVD.
The maps clearly show a spatial distribution of hemo-
globin flow, concentration, and oxygenation. In a healthy
subject (Fig 5), spatial heterogeneity in [O2Hb] and
[tHb] was noted, with the highest values proximal and
medial. SvO2 varies slightly depending on location, but
remains within the physiologic range.
Comparison between subjects B and C (Fig 5) demon-
strates that although the ABI is almost identical, the hemo-
globin concentration changes and SvO2 differ. In both
subjects the patterns of the hemoglobin concentration
changes and SvO2 appear more heterogeneous than in the
healthy subject. SvO2 dips below the physiologic range in
some locations. Of interest, these regions are not in the
distal part of the calf muscle.
The maps for patients D, E, and F (Fig 6) express a
different pattern of hemoglobin concentration change dur-
ing venous occlusion. After an initial increase during ve-
nous occlusion, [O2Hb] decreases. [tHb] increases contin-
uously, indicating that arterial inflow is not blocked by cuff
pressure. Nevertheless, the decrease in [O2Hb] demon-
strates that oxygen supply does not fill oxygen demand.
Since VO2 did not change during venous occlusion, the
most probable reason for the decrease in [O2Hb] is insuf-
ficient perfusion pressure, which cannot counterbalance the
Table II. Proximal-distal differences for parameters in patients with documented PVD and with risk factors for PVD
and in healthy subjects
Patients with
documented PVD
Patients at risk
for PVD Healthy subjects
[O2Hb] 60s (mol/L) 0.86  3.59 2.66  7.87 3.38  3.22
†
[HHb] 60s (mol/L) 1.14  1.56 0.94  2.80 1.18  0.67†
[tHb] 60s (mol/L) 2.01  3.75 3.60  9.38 4.56  3.36†
[O2Hb] 180 s (mol/L) 2.54  3.08* 	0.13  6.23 3.88  4.46*
[HHb] 180 s (mol/L) 3.03  6.07 0.03  7.78 2.19  2.12†
[tHb] 180 s (mol/L) 5.57  6.78 	0.09  9.87 6.07  3.63†
HF (mol/100 mL/min) 0.52  1.04 0.37  1.01 0.70  0.60†
BF (mL/100 g/min) 0.23  0.45 0.15  0.46 0.30  0.26†
VO2 (mL/100 g/min) 0.003  0.021 0.013  0.024 0.011  0.009
†
SvO2 (%) 3.6  17.8 	6.1  7.7* 	3.9  4.6
†
, increase during venous occlusion after 60 or 180 seconds; O2Hb, oxyhemoglobin; HHb, deoxyhemoglobin; tHb, total hemoglobin; HF, hemoglobin flow;
BF, blood flow; VO2, oxygen consumption; SvO2, venous oxygen saturation.
*P  .05.
†P  .005.
JOURNAL OF VASCULAR SURGERY
May 20031022 Wolf et al
Fig 5. Color-coded maps represent view from posterior on subject lateral calf muscles during venous occlusion.
Columns represent variables O2Hb, total hemoglobin (tHb), and SvO2, and rows correspond to a particular subject.
Scale for each parameter is given at bottom. Subject A is characteristic of healthy subjects, with increase in [O2Hb] and
[tHb] is higher proximally and medially. SvO2 is above 70% throughout maps. In subject B, localized effect with lower
increase in [O2Hb] and [tHb] and very low SvO2 is noted, while rest of muscle is perfused and oxygenated normally.
In subject C, SvO2 drops considerably distally. ABI, Ankle-brachial index.
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increasing intravascular pressure due to venous occlusion.
The regions with declining [O2Hb] overlap regions with
low SvO2. Again, the lowest SvO2 values are not necessarily
in the distal part of the calf muscle.
We would like to point out that one of the subjects
(Subject E in Fig 6) with decreasing [O2Hb] and regions
with low SvO2 had a normal ABI (ankle pressure, 176 mm
Hg; brachial blood pressure, 150/90 mm Hg). Since such
irregular patterns and, more important, such low SvO2 were
not observed in healthy subjects and not in all patients of
similar age, they are most likely caused by vascular condi-
tions and may be related to PVD.
Differing patterns were also observed between patients
of the same age. Therefore the reason for observed differ-
ences lies within the conditions of each person rather than
in age difference.
The variation within maps was significantly higher in
patients compared with the healthy subjects. This reflects
local irregularities in hemoglobin flow, concentration, and
oxygenation, which can best be seen in Figs 5 and 6. These
irregularities are larger than the normal spatial variability in
healthy subjects, where higher values in the proximal and
medial part were found (Fig 5).
Although these maps were generated offline, such pa-
rameters can easily be displayed in real time as venous
occlusion proceeds. Inasmuch as the method is painless and
requires no exertion, the maps enable identification of local
irregularities in hemoglobin flow, concentration, and oxy-
Fig 6. Maps depict phenomenon of decrease in [O2Hb] from 60 to 180 seconds during venous occlusion. [O2Hb]
decreases despite continuous increase in total hemoglobin (tHb). Effect can be generalized (subject D) or localized
(subject E). Again, maps show it is possible to identify regions of irregular hemoglobin concentration increase and SvO2.
Color-coded maps are analogous with those in Fig 5. ABI, Ankle-brachial index.
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genation. We believe our results reinforce the capabilities of
NIRS as a promising new tool for diagnostic and follow-up
purposes in treating PVD.
Limitations of the method. It is important that
pressure to achieve venous occlusion is less than perfusion
pressure so as not to impair arterial inflow, particularly in
severe PVD, where perfusion pressure may be low. During
venous occlusion [tHb] increased continuously, although
at a slower rate toward the end, which demonstrates that
arterial inflow was never completely blocked.
The current setup of NIRS was optimized for high
spatial resolution and is sensitive to movement artifacts.
During a venous occlusion protocol this poses no problem,
which is confirmed by the low error of measurement during
repeated measurements. For protocols involving move-
ment, a different NIRS setup with lower spatial resolution is
resistant to movement artifacts.43
The penetration depth of light through tissue is limited
and may be influenced by adipose tissue thickness. Thus it is
not possible to interrogate muscle tissue, which is more
than several centimeters deep. Currently, procedures are
being developed that allow three-dimensional images of
tissue.
The number of subjects included in this study is limited
but adequate for a feasibility study. Further studies are
required to confirm the promising results and to validate
the new method.
CONCLUSION
NIRS offers the unique capability of simultaneously
measuring flow, concentration, and oxygenation of hemo-
globin in small blood vessels, such as arterioles, capillaries,
and venules, several centimeters deep in tissue. Combining
NIRS with the venous occlusion method may provide a
promising assessment method for PVD that is noninvasive,
bedside-feasible, repeatable, and requires no exercise,
which is particularly important in patients with limited
locomotion capability. Significant correlations were found
between ABI and increase in [O2Hb], [tHb], hemoglobin
flow, and SvO2 at distal locations of calf muscle in the
patients. The maps over a large area of calf muscle revealed
localized irregularities in [O2Hb], [tHb], and SvO2.
As the method becomes more sophisticated and subject
to further investigations, NIRS may offer great potential as
a tool for diagnostic and follow-up applications, not only in
patients with PVD but whenever hemoglobin flow, con-
centration, and oxygenation in human tissue may be im-
paired.
We thank all the subjects and particularly the patients
for their contribution to this study; and Dr Alan Martin-
dale, Director of Sports Medicine, University of Illinois at
Urbana-Champaign, for his kind support.
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